Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-06

Clinical Trial Update: HDR Focal: Feasibility Study [NA]

View source ↗

Summary

This clinical trial update indicates that an HDR Focal Feasibility Study for prostate cancer is currently recruiting, with no specified phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | NA | Status: RECRUITING